{"version":"1.0","type":"link","title":"IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort.","author_name":"Martin-Broto J 외","author_url":"https://prs-insight.online/author/Martin-Broto%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167666","thumbnail_width":1200,"thumbnail_height":630}